Clinical Trial

Efficacy and Safety of Intravenous Lidocaine Versus Placebo in Patients Receiving Morphine-rachi Analgesia

Study acronym: LIDORACHI
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the superiority of IV lidocaine combined with morphine spinal anesthesia versus placebo combined with morphine spinal anesthesia, in reducing postoperative morphine consumption at 48 hours, in patients undergoing major digestive or abdominal surgery by laparotomy.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-07-21; most recent amendment 2026-06-30.
Trial Details
NCT Number NCT07076641
Lead Sponsor GCS Ramsay Santé pour l'Enseignement et la Recherche
Collaborators: Euraxi Pharma
Conditions Digestive System Disease, Surgery
Enrollment 76 participants
Start Date 2026-07
Primary Completion 2027-07-30 (estimated)
Study Completion 2027-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-01